Filter News
Area of Research
News Type
News Topics
- (-) Biotechnology (6)
- (-) Summit (9)
- 3-D Printing/Advanced Manufacturing (20)
- Advanced Reactors (3)
- Artificial Intelligence (26)
- Big Data (10)
- Bioenergy (22)
- Biology (29)
- Biomedical (7)
- Buildings (14)
- Chemical Sciences (24)
- Clean Water (5)
- Climate Change (31)
- Composites (6)
- Computer Science (23)
- Coronavirus (4)
- Critical Materials (6)
- Cybersecurity (9)
- Decarbonization (30)
- Education (3)
- Emergency (1)
- Energy Storage (21)
- Environment (43)
- Exascale Computing (15)
- Fossil Energy (2)
- Frontier (19)
- Fusion (9)
- Grid (16)
- High-Performance Computing (33)
- Hydropower (3)
- Irradiation (2)
- Isotopes (11)
- Machine Learning (15)
- Materials (59)
- Materials Science (16)
- Mathematics (2)
- Mercury (2)
- Microelectronics (2)
- Microscopy (7)
- Molten Salt (1)
- Nanotechnology (7)
- National Security (21)
- Net Zero (5)
- Neutron Science (32)
- Nuclear Energy (21)
- Partnerships (24)
- Physics (14)
- Polymers (4)
- Quantum Computing (12)
- Quantum Science (9)
- Renewable Energy (2)
- Security (3)
- Simulation (29)
- Software (1)
- Space Exploration (4)
- Sustainable Energy (17)
- Transportation (18)
Media Contacts
In a discovery aimed at accelerating the development of process-advantaged crops for jet biofuels, scientists at ORNL developed a capability to insert multiple genes into plants in a single step.
Oak Ridge National Laboratory scientists exploring bioenergy plant genetics have made a surprising discovery: a protein domain that could lead to new COVID-19 treatments.
A team of researchers from ORNL was recognized by the National Cancer Institute in March for their unique contributions in the fight against cancer.
A team of scientists led by the Department of Energy’s Oak Ridge National Laboratory designed a molecule that disrupts the infection mechanism of the SARS-CoV-2 coronavirus and could be used to develop new treatments for COVID-19 and other viral diseases.
As part of a multi-institutional research project, scientists at ORNL leveraged their computational systems biology expertise and the largest, most diverse set of health data to date to explore the genetic basis of varicose veins.